Your account is not claimed yet. You can sign up with ORCID to claim your account.

Douglas Sipp (Doug Sipp)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Embryonic Stem Cells

Genome Wide Analysis

Top Venues

NPJ Regenerative medicine

Science translational medicine

Developing world bioethics

Development (Cambridge, England)

RIKEN Center for Advanced Intelligence Project

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RIKEN Center for Advanced Intelligence Project Apr 1o 2017

Japan

Researcher

Publications

Hideyuki Okano, Douglas Sipp
New trends in cellular therapy. Development (Cambridge, England) 147 (18) (2020)
Douglas Sipp, Timothy Caulfield, Jane Kaye, Jan Barfoot, Clare Blackburn, Sarah Chan, Michele De Luca, Alastair Kent, Christopher McCabe, Megan J Munsie, Margaret Sleeboom-Faulkner, Jeremy Sugarman, Esther van Zimmeren, Amy Zarzeczny, John E J Rasko
Marketing of unproven stem cell-based interventions: A call to action. Science translational medicine 9 (397) (2018)
Claire Horner, Evelyn Tenenbaum, Douglas Sipp, Zubin Master
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions. NPJ Regenerative medicine 3 (2018)
Douglas Sipp
The malignant niche: safe spaces for toxic stem cell marketing. NPJ Regenerative medicine 2 (2017)
Douglas Sipp
Cell Churches and Stem Cell Marketing in South Korea and the United States. Developing world bioethics 17 (3) (2016)